06/02/2020
New Medical Marijuana Conditions Approved by Regulations Review Committee
Approved regulations add two conditions to medical marijuana program
(HARTFORD) – Today, the Regulations Review Committee of the General Assembly approved Department of Consumer Protection (DCP) regulations that add two (2) new conditions to the Medical Marijuana Program for adults only. These additions are based on recommendations made by the Medical Marijuana Board of Physicians.
Additions to the program are:
- Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention; and,
- Ehlers-Danlos Syndrome.
“I am grateful to the Board of Physicians and the Regulations Review Committee for considering these conditions so carefully,” said Consumer Protection Commissioner Michelle H. Seagull, “In particular, the discussion about chronic pain has been informed and thoughtful. I am pleased that we have been able to hear from the public, and the board has been able to make recommendations that will give patients, and the medical professionals who treat them more options for care.”
The last step in this process is for DCP to submit the regulations to the Secretary of the State's Office, who will post the regulations online. At that point, the regulations will be final.
There are currently 41,254 patients benefitting from the medical marijuana program, 1,270 certifying physicians and APRNs, and a new total of 38 conditions approved for adults and 10 for patients under 18.
For more information about the medical marijuana program, please visit www.ct.gov/DCP/mmp. Those with questions or concerns may email dcp.mmp@ct.gov.
###
Media Contact:
Lora Rae Anderson
lorarae.anderson@ct.gov
(860) 247-8711 (cell)
- Twitter: DCP on Twitter
- Facebook: DCP on Facebook